Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Translocator Protein 18 kDa (TSPO) Expression in Multiple Sclerosis Patients.
A case of Guillain-Barré syndrome with meningeal irritation.
Effects of Three Months Fingolimod Therapy on Heart Rate.
Multi-parametric structural magnetic resonance imaging in relation to cognitive dysfunction in long-standing multiple sclerosis.
Disability Identity Predicts Lower Anxiety and Depression in Multiple Sclerosis.
Prevalence of Incidental Narrowing of the Superior Segment of the Internal Jugular Vein in Patients Without Multiple Sclerosis.
Estrogen receptor (ER) β expression in oligodendrocytes is required for attenuation of clinical disease by an ERβ ligand.
Multiple sclerosis: Study in MS reveals impairments in 'theory of mind'
Perivascular spaces in MS patients at 7 Tesla MRI: A marker of neurodegeneration?
Involvement of JAK/STAT signaling in the effect of cornel iridoid glycoside on experimental autoimmune encephalomyelitis amelioration in rats.
Drug therapy for multiple sclerosis.
The visual pathway as a model to understand brain damage in multiple sclerosis.
Common mechanisms in neurodegeneration and neuroinflammation: a BrainNet Europe gene expression microarray study.
Multiple Sclerosis State of the Art (SMART): A Qualitative and Quantitative Analysis of Therapy's Adherence, Hospital Reliability's Perception, and Services Provided Quality.
The safety risks of innovation: the FDA's Expedited Drug Development Pathway.
Myelin-derived lipids modulate macrophage activity by liver x receptor activation.
Epileptic seizures in Japanese patients with multiple sclerosis and neuromyelitis optica.
The Gut Microbiome and the Brain.
[Effects of shugan jianpi gusui recipe on multiple sclerosis recurrence: a primary report].
Beneficial effects of Rituximab in patients with anti-MAG (myelin-associated glycoprotein) neuropathy: case reports.
Effects of exercise training on fatigue in multiple sclerosis: a meta-analysis.
Tobacco smoking and excess mortality in multiple sclerosis: a cohort study.
Dimethyl fumarate: a review of its use in patients with relapsing-remitting multiple sclerosis.
Vitamin D in inflammatory diseases.
Defining the new end point for multiple sclerosis treatment.

Pages